IntraOp and GMV Agreement Brings 3D Treatment Planning to Electron-beam IORT Users Globally
SUNNYVALE, Calif. (PRWEB) April 10, 2018 -- IntraOp Medical Corporation, the leading innovator in electron radiation therapy devices, and GMV, a global leader in intraoperative radiation therapy planning, announce a strategic agreement to advance the field of oncology. Under the agreement, IntraOp will be the exclusive distributor of GMV’s radiance® intraoperative radiation therapy (IORT) planning system for electron-beam IORT users, globally. GMV radiance is the only commercially available treatment planning system designed specifically for IORT.
The IntraOp® Mobetron® is the only self-shielded, portable LINAC capable of providing electron-beam IORT in a standard operating room, unifying surgeons and radiation oncologists as an effective team in the fight against cancer. Electron IORT has been used for locally advanced and recurrent cancers, achieving excellent clinical results in both local control and survival, especially in indications where it is difficult to obtain clear surgical margins such as pancreatic cancer, colorectal cancers, head and neck cancers, and soft tissue sarcomas. For breast cancer the Mobetron can administer in a single, two-minute treatment the equivalent of six weeks of conventional external-beam x-ray radiation.
Powered with GMV’s radiance treatment planning system, Mobetron IORT treatments will significantly increase in precision and effectiveness, enabling physicians to simulate and plan treatments in 3D utilizing CT images. Through its high quality multiplanar reconstruction engine, radiance enables physicians to obtain a sophisticated volumetric visualization of the patient treatment area to perform advanced planning and simulation including applicator positioning, contouring, and dose calculations though Pencil Beam and Monte Carlo algorithms. Effects of beam misalignment, gaps, bolus, changes of penumbra and tissue inhomogeneities in realistic patient geometrics, as required in the report of TG-72 of the AAPM, can be properly addressed with radiance.
“We are delighted to be adding radiance to our product portfolio,” stated Derek DeScioli, Vice President Global Sales at IntraOp. “IntraOp has always been at the forefront in advancing IORT technology and radiance represents a significant improvement in the sophistication in treatment planning and delivery, empowering our physicians to deliver better results to their patients,” added DeScioli.
“We are excited to launch this agreement with IntraOp, the electron-beam IORT world leader who shares our vision to transform the world by developing and integrating state-of-the-art technology”, said Luis Fernando Álvarez-Gascón Pérez, General Manager of GMV Secure e-Solutions. “Enabling accurate planning of the radio surgical procedure in advance is GMV’s contribution to the safety and optimal results of intraoperative radiotherapy, which we support as the best way to shorten treatment and recovery times for patients”.
About IntraOp Medical Corporation
IntraOp® is the leading innovator of electron radiation devices for treating cancer as an adjunct to invasive surgical procedures. As the developer and manufacturer of Mobetron®, IntraOp pioneered the world’s first portable, self-shielded LINAC used for electron-based Intraoperative Radiation Therapy (IORT). More than 18,000 patients in 17 countries have benefited from Mobetron IORT. Based in Sunnyvale, California, IntraOp is a cancer care company uniting radiation and surgical oncology in the fight against cancer. For more information please visit http://www.intraop.com
About GMV
GMV is a privately owned technology business group with an international presence. Founded in 1984, GMV offers its solutions, services and products in very diverse sectors: Aeronautics, Banking and Finances, Space, Defense, Health, Cybersecurity, Intelligent Transportation Systems, Automotive, Telecommunications, and Information Technology for Public Administration and large corporations. The leadership position that GMV has attained in these sectors is based on an in-depth knowledge of client needs, which allows us to deliver solutions specifically tailored to their individual requirements. GMV is headquartered in Spain, and has subsidiaries in Germany, Colombia, France, the USA, Malaysia, Poland, Portugal, the UK and Romania. In 2017, it had revenues of more than 160 million euros and a workforce of nearly 1,600 professionals. For more information please visit http://www.gmv.com
###
Jessica Hidalgo, IntraOp Medical Corporation, http://intraop.com/, +1 408-636-1020 Ext: 122, [email protected]
Share this article